52
Views
31
CrossRef citations to date
0
Altmetric
Research Article

Does clinical diagnosis indicate ocular chlamydial infection in areas with a low prevalence of trachoma?

, , , , , , , , , , , & show all
Pages 263-269 | Published online: 08 Jul 2009

References

  • Murioz B, West S. Trachoma: The forgotten cause of blindness. Epidemiol Rev. 1997;19:205–217.
  • Bailey RL, Arullendran P, Whittle HC, Mabey DC. Randomised controlled trial of single-dose azithromycin in treatment of trachoma. Lancet 1993;342: 453–456.
  • West S, Murioz B, Bobo L, Quinn TC, Mkocha H, Lynch M, et al. Nonocular Chlamydia infection and risk of ocular reinfection after mass treatment in a trachoma hyperendemic area. Invest Ophthalmol Vis ScL 1993;34:3194–3198.
  • Report of the First Meeting of the W.H.O. Alliance for the Global Elimination of Trachoma. Geneva: World Health Organization, 1997.
  • Schachter J. Diagnosis of human chlamydial infections. In: Stephens Rea, editor. Ninth International Symposium on Human Chlamydial Infection. Napa, California: Ninth International Symposium on Human Chlamydial Infection, 1998;577–586.
  • Thylefors B, Dawson CR, Jones BR, West SK, Taylor HR. A simple system for the assessment of trachoma and its complications. Bull World Health Organ. 1987;65: 477–483.
  • Bailey RL, Hayes L, Pickett M, Whittle HC, Ward ME, Mabey DC. Molecular epidemiology of trachoma in a Gambian village. Br J OphthalmoL 1994;78:813–817.
  • Bobo LD, Novak N, Murioz B, Hsieh YH, Quinn TC, West S. Severe disease in children with trachoma is associated with persistentChlamydia trachomatis infection. J Infect Dis. 1997;176:1524–1530.
  • Baral K, Osaki S, Shreshta B, Panta CR, Boulter A, Pang F, et al. Reliability of clinical diagnosis in identifying infectious trachoma in a low-prevalence area of Nepal. Bull World Health Organ. 1999;77: 461–466.
  • Schachter J, West SK, Mabey D, Dawson CR, Bobo L, Bailey R, et al. Azithromycin in control of trachoma. Lancet 1999;354:630–635.
  • Laming AC, Hallsworth PJ. Detection of chlamydial nucleic acid in follicular trachoma. Med J Aust. 1999;170:190.
  • Lietman T, Dawson C, Osaki S, Zegans M. Clinically active trachoma versus Chlamydia infection. Med J Aust. 2000;172:93–94.
  • Liu H, Ou B, Paxton A, Zhao P, Xu J, Long D, et al. Rapid assessment oftrachoma in Hainan Province, China: Validation of the new World Health Organization methodology. Ophthalmic EpidemioL 2002;9: 97–104.
  • Osaki Holm S, Jha H, Bhatta R, Chaudhary J, Thapa B, Pokhrel R, et al. Azithromycin Distribution Strategies for Trachoma. Bull World Health Organ. 2001;79: 194–200.
  • Arffa RC, Grayson M. Grayson's diseases of the cornea. 3rd ed. St. Louis, MO: Mosby-Year Book,1991.
  • Thygeson P, Hanna L, Dawson C, Zichosh J, Jawetz E. Inoculation of Human Volunteer with EggGrown Inclusion Conjunctivitis Virus. Am J OphthalmoL 1962;53: 786–795.
  • Dawson CR, Jawetz E, Hanna L, Rose L, Wood T, Thygeson P. Experimental inclusion conjunctivities in man: Partial resistance to reinfection. Am J EpidemioL 1966;84:411–425.
  • Conclusions and Recommendations. In: First National Workshop on the Assessment and Management of Trachoma in the People's Republic of China. Beijing, China: WHO,1999.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.